A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...

The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

With a federal grant in hand, researchers at the health system and national lab will try to hit fast forward on the long and ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups, according to a new study. The ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

Researchers at the University of Iowa are part of a project designed to enhance treatment options for a common form of liver ...

UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...